Study of a new catheter for treating atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests a new catheter to treat atrial fibrillation (AF), a heart rhythm problem, in people with symptoms. It aims to see if the treatment is safe and works well for people whose AF comes and goes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have had at least two episodes of atrial fibrillation in the last 6 months that caused symptoms.
- You have had at least one episode of atrial fibrillation confirmed by a heart monitor (ECG) in the last year.
- You have tried at least one heart rhythm medication that didn't work or caused side effects.
- You have not had atrial fibrillation that lasted continuously for more than 7 days.
- You do not have certain heart conditions or devices (like a pacemaker) that would make the procedure unsafe.
- You are willing and able to follow the study schedule and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new catheter and system for people who have had one previous ablation for atrial fibrillation but still have symptoms. It aims to see if a repeat procedure can safely and effectively treat recurrent episodes.
This trial tests a new tool called FARAFLEX that uses pulsed electrical energy to treat atrial fibrillation (an irregular heart rhythm). The goal is to see if this method can safely stop AF symptoms in people whose medications haven't worked.
This study tests a new type of catheter ablation (a procedure that uses energy to treat irregular heartbeats) for atrial fibrillation—a common heart rhythm problem. You may qualify if you have recurring irregular heartbeats that haven't responded well to heart medications and are planning to have this procedure.
This trial tests a new catheter and mapping system designed to treat paroxysmal atrial fibrillation (AF), which is a type of irregular heartbeat that comes and goes. If you have this condition, the study aims to see how well the new system works with a minimally invasive procedure.
This trial studies a heart procedure using the Affera SpherePVI system to treat paroxysmal (comes and goes) or persistent atrial fibrillation. It’s for people who still have symptoms despite at least one anti-arrhythmia medicine, and who are good candidates for catheter ablation.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
Hear when a new Paroxysmal Atrial Fibrillation (PAF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.